단일세포 오믹스 시장 분석 및 예측(-2035년) : 유형, 제품, 기술, 용도, 최종사용자, 기기

The global Single-cell Omics Market is projected to grow from $2.2 billion in 2025 to $7.8 billion by 2035, at a compound annual growth rate (CAGR) of 13.5%. The global single-cell omics market is supported by expanding investments in genomics and precision medicine. According to the National Institutes of Health (NIH, 2025), the U.S. allocated over $3.8 billion annually toward genomics and related research programs, including single-cell studies. The World Health Organization (WHO, 2024) reports more than 20 million new cancer cases globally, increasing demand for single-cell analysis in oncology. Additionally, the European Commission (Horizon Europe, 2025) has committed around $96 billion toward research and innovation, including life sciences and omics technologies. Furthermore, the UK Biobank (2025) continues to expand its dataset beyond 500,000 participants, supporting large-scale single-cell and genomic research initiatives.

In the single-cell omics market, the application segment includes oncology, cell biology, immunology, neurology, and other research areas. Oncology dominates the market, accounting for approximately $451.1 Million in 2025, driven by increasing use of single-cell sequencing for tumor heterogeneity analysis, biomarker discovery, and precision oncology applications. Cell biology focuses on understanding cellular structure, function, and gene expression at single-cell resolution. Immunology applications are expanding rapidly as researchers study immune cell dynamics, disease mechanisms, and vaccine responses. Neurology is also gaining traction with rising research into brain disorders and neural mapping, while other applications include developmental and infectious disease studies.

In the single-cell omics market, the product segment includes instruments, consumables & reagents, and software & services. Consumables & reagents dominate the segment, accounting for approximately $470.8 Million in 2025, due to their continuous requirement in sample preparation, library construction, and sequencing workflows. Instruments such as sequencing platforms, flow cytometers, and microfluidics systems form the core of single-cell analysis infrastructure. Software & services are increasingly important, enabling advanced data analysis, visualization, and interpretation of complex datasets. The integration of AI and bioinformatics tools is further enhancing research efficiency, supporting scalable and high-precision single-cell studies across global life science applications.

Geographical Overview

North America is the largest regional market for single-cell omics, accounting for approximately 43.68% of the global market share in 2025, supported by strong research infrastructure, high funding levels, and early adoption of advanced genomic technologies. The presence of leading biotechnology and pharmaceutical companies, along with extensive support from organizations such as the National Institutes of Health, continues to drive innovation and large-scale research initiatives. The region also benefits from a well-established healthcare system and growing focus on precision medicine and cancer research.

The Asia-Pacific region is the fastest-growing market, projected to expand at a CAGR of approximately 16.7% during the forecast period. This growth is driven by increasing government investments in genomics and life sciences, rising healthcare expenditure, and rapid development of research infrastructure. Countries such as China, Japan, and India are actively promoting precision medicine and large-scale population genomics programs. Additionally, the region's large patient base, growing prevalence of chronic diseases, and expanding biotechnology sector are accelerating the adoption of single-cell omics technologies.

Key Trends and Drivers

Innovations Driving Single-Cell Analysis

The single-cell omics market is witnessing rapid innovation driven by the need for high-throughput, scalable, and cost-efficient analysis technologies. Researchers are increasingly adopting advanced platforms that enable deeper cellular insights, integration of multiomics, and support for large-scale studies in areas such as oncology and drug discovery. The focus is also shifting toward automation-ready solutions that improve efficiency and data accuracy while reducing costs for broader accessibility. For instance, in October 2025, 10x Genomics launched its next-generation Flex assay, enabling analysis of up to 100 million cells per week, highlighting the growing demand for high-volume, high-resolution single-cell analysis solutions.

Increasing Use in Drug Discovery and Biomarker Identification

The increasing use of single-cell omics in drug discovery and biomarker identification is a key driver of market growth. These technologies enable precise identification of cell-type-specific drug targets and deeper understanding of complex disease mechanisms by integrating genomics, transcriptomics, and proteomics. Single-cell RNA sequencing generates high-resolution data, helping researchers analyze cellular heterogeneity and improve clinical trial outcomes. Additionally, AI-driven analysis of large datasets supports prediction of therapeutic responses and disease progression, enhancing drug development efficiency. For instance, in February 2025, IIT Madras launched the SCOT Lab to accelerate single-cell-based drug discovery and early diagnostics, highlighting growing adoption in precision medicine.

Research Scope

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by End-User
• 2.2 Key Market Highlights by Application
• 2.3 Key Market Highlights by Type
• 2.4 Key Market Highlights by Product
• 2.5 Key Market Highlights by Instruments
• 2.6 Key Market Highlights by Technology

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTLE Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by End-User (2020-2035)
  • 4.1.1 Academic & Research Institutes
  • 4.1.2 Pharmaceutical & Biotechnology Companies
  • 4.1.3 Hospital & Diagnostic Laboratories
  • 4.1.4 CROs
• 4.2 Market Size & Forecast by Application (2020-2035)
  • 4.2.1 Oncology
  • 4.2.2 Cell Biology
  • 4.2.3 Immunology
  • 4.2.4 Neurology
  • 4.2.5 Others
• 4.3 Market Size & Forecast by Type (2020-2035)
  • 4.3.1 Genomics
  • 4.3.2 Transcriptomics
  • 4.3.3 Proteomics
  • 4.3.4 Metabolomics
• 4.4 Market Size & Forecast by Product (2020-2035)
  • 4.4.1 Instruments
  • 4.4.2 Consumables & Reagents
  • 4.4.3 Software & Services
• 4.5 Market Size & Forecast by Instruments (2020-2035)
  • 4.5.1 Single-Cell Sequencers
  • 4.5.2 Single-Cell Analyzers
  • 4.5.3 Others
• 4.6 Market Size & Forecast by Technology (2020-2035)
  • 4.6.1 Microfluidics
  • 4.6.2 Mass Spectrometry
  • 4.6.3 Next-Generation Sequencing
  • 4.6.4 Protein Microarrays

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Technology
    • 5.2.1.4 Instruments
    • 5.2.1.5 Application
    • 5.2.1.6 End-User
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Technology
    • 5.2.2.4 Instruments
    • 5.2.2.5 Application
    • 5.2.2.6 End-User
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Technology
    • 5.2.3.4 Instruments
    • 5.2.3.5 Application
    • 5.2.3.6 End-User
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Technology
    • 5.3.1.4 Instruments
    • 5.3.1.5 Application
    • 5.3.1.6 End-User
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Technology
    • 5.3.2.4 Instruments
    • 5.3.2.5 Application
    • 5.3.2.6 End-User
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Technology
    • 5.3.3.4 Instruments
    • 5.3.3.5 Application
    • 5.3.3.6 End-User
• 5.4 Europe Market Size (2020-2035)
  • 5.4.1 Germany
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Technology
    • 5.4.1.4 Instruments
    • 5.4.1.5 Application
    • 5.4.1.6 End-User
  • 5.4.2 France
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Technology
    • 5.4.2.4 Instruments
    • 5.4.2.5 Application
    • 5.4.2.6 End-User
  • 5.4.3 United Kingdom
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Technology
    • 5.4.3.4 Instruments
    • 5.4.3.5 Application
    • 5.4.3.6 End-User
  • 5.4.4 Spain
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Technology
    • 5.4.4.4 Instruments
    • 5.4.4.5 Application
    • 5.4.4.6 End-User
  • 5.4.5 Italy
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Technology
    • 5.4.5.4 Instruments
    • 5.4.5.5 Application
    • 5.4.5.6 End-User
  • 5.4.6 Rest of Europe
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Technology
    • 5.4.6.4 Instruments
    • 5.4.6.5 Application
    • 5.4.6.6 End-User
• 5.5 Asia-Pacific Market Size (2020-2035)
  • 5.5.1 China
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Technology
    • 5.5.1.4 Instruments
    • 5.5.1.5 Application
    • 5.5.1.6 End-User
  • 5.5.2 India
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Technology
    • 5.5.2.4 Instruments
    • 5.5.2.5 Application
    • 5.5.2.6 End-User
  • 5.5.3 South Korea
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Technology
    • 5.5.3.4 Instruments
    • 5.5.3.5 Application
    • 5.5.3.6 End-User
  • 5.5.4 Japan
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Technology
    • 5.5.4.4 Instruments
    • 5.5.4.5 Application
    • 5.5.4.6 End-User
  • 5.5.5 Australia
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Technology
    • 5.5.5.4 Instruments
    • 5.5.5.5 Application
    • 5.5.5.6 End-User
  • 5.5.6 Taiwan
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Technology
    • 5.5.6.4 Instruments
    • 5.5.6.5 Application
    • 5.5.6.6 End-User
  • 5.5.7 Rest of APAC
    • 5.5.7.1 Type
    • 5.5.7.2 Product
    • 5.5.7.3 Technology
    • 5.5.7.4 Instruments
    • 5.5.7.5 Application
    • 5.5.7.6 End-User
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Technology
    • 5.6.1.4 Instruments
    • 5.6.1.5 Application
    • 5.6.1.6 End-User
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Technology
    • 5.6.2.4 Instruments
    • 5.6.2.5 Application
    • 5.6.2.6 End-User
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Technology
    • 5.6.3.4 Instruments
    • 5.6.3.5 Application
    • 5.6.3.6 End-User
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Technology
    • 5.6.4.4 Instruments
    • 5.6.4.5 Application
    • 5.6.4.6 End-User
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Technology
    • 5.6.5.4 Instruments
    • 5.6.5.5 Application
    • 5.6.5.6 End-User

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 10x Genomics
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Illumina, Inc.
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Standard BioTools Inc.
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Thermo Fisher Scientific Inc.
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 Precision Cell Systems, Inc.
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Bio-Rad Laboratories, Inc.
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Precigenome LLC
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Becton, Dickinson and Company
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Pacific Biosciences
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Menarini Group
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 PerkinElmer
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Takara Bio
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Bruker
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Danaher Corporation (Cytiva)
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 QIAGEN (Parse Biosciences)
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Zifo
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 MISSION BIO
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 BICO (CELLENION)
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 CelLBxHealth (ANGLE plc.)
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Creative Biolabs
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us